Cargando…
Genetic Deletion of the Stromal Cell Marker CD248 (Endosialin) Protects against the Development of Renal Fibrosis
BACKGROUND: Tissue fibrosis and microvascular rarefaction are hallmarks of progressive renal disease. CD248 is a transmembrane glycoprotein expressed by key effector cells within the stroma of fibrotic kidneys including pericytes, myofibroblasts and stromal fibroblasts. In human disease, increased e...
Autores principales: | Smith, Stuart William, Croft, Adam Paul, Morris, Hannah Louise, Naylor, Amy Jane, Huso, David Leonard, Isacke, Clare Marie, Savage, Caroline Olivia Susan, Buckley, Christopher Dominic |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872467/ https://www.ncbi.nlm.nih.gov/pubmed/26633297 http://dx.doi.org/10.1159/000438754 |
Ejemplares similares
-
A Differential Role for CD248 (Endosialin) in PDGF-Mediated Skeletal Muscle Angiogenesis
por: Naylor, Amy J., et al.
Publicado: (2014) -
CD248/endosialin critically regulates hepatic stellate cell proliferation during chronic liver injury via a PDGF-regulated mechanism
por: Wilhelm, Annika, et al.
Publicado: (2016) -
CD248 expression on mesenchymal stromal cells is required for post-natal and infection-dependent thymus remodelling and regeneration
por: Lax, Siân, et al.
Publicado: (2012) -
Endosialin/CD248 may be a potential therapeutic target to prevent the invasion and metastasis in osteosarcoma
por: Kondo, Yumiko, et al.
Publicado: (2022) -
Hypoxia-inducible Factor may Induce the Development of Liver Fibrosis in Budd–Chiari Syndrome by Regulating CD248/endosialin Expression: A Hypothesis
por: Tian, Ye, et al.
Publicado: (2018)